2002Biomedical ReviewsOpen access

Neuromelanin-containing, catecholaminergic neurons in the human brain: ontogenetic aspects, development and aging

Dimitar E. Itzev, Wladimir Ovtscharoff, Enrico Marani, Kamen G. Usunoff

Open full text 6 citations

Abstract

The present review compiles data on the development and aging ofneuromelanin (NM)-containing neurons in the central nervous system. Neuromelanin is brownish-to-black pigment that accumulates in the catecholaminergic (noradrenergic and dopaminergic) neurons and is a reliable natural marker that delineates the A1-A14 catecholaminergic groups of Dahlstrom and Fuxe in the human brain. The pigmentation of noradrenergic locus ceruleus neurons starts earlier than that of dopaminergic substantia nigra, but also a considerable individual variability is present. The pigmentation is well advanced in adolescence. The data at what age the maximal pigmentation is reached are controversial, as are the data on the cell loss in the NM-containing neuronal populations by normal aging. Thus, the participation ofNM in the pathogenesis of Parkinson`s disease remains enigmatic. Biomedical Reviews 2002; 13: 39-47.

Open-access reader

About this research paper

What this paper is about

The present review compiles data on the development and aging ofneuromelanin (NM)-containing neurons in the central nervous system. Neuromelanin is brownish-to-black pigment that accumulates in the catecholaminergic (noradrenergic and dopaminergic) neurons and is a reliable natural marker that delineates the A1-A14 catecholaminergic groups of Dahlstrom and Fuxe in the human brain. The pigmentation of noradrenergic locus ceruleus neurons starts earlier than that of dopaminergic substantia nigra, but also a considerable individual variability is present. The pigmentation is well advanced in adolescence. The data at what age the maximal pigmentation is reached are controversial, as are the data on the cell loss in the NM-containing neuronal populations by normal aging. Thus, the participation ofNM in the pathogenesis of Parkinson`s disease remains enigmatic. Biomedical Reviews 2002; 13: 39-47.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The present review compiles data on the development and aging ofneuromelanin (NM)-containing neurons in the central nervous system. Neuromelanin is brownish-to-black pigment that accumulates in the catecholaminergic (noradrenergic and dopaminergic) neurons and is a reliable natural marker that delineates the A1-A14 catecholaminergic groups of Dahlstrom and Fuxe in the human brain. The pigmentation of noradrenergic locus ceruleus neurons starts earlier than that of dopaminergic substantia nigra, but also a considerable individual variability is present. The pigmentation is well advanced in adolescence. The data at what age the maximal pigmentation is reached are controversial, as are the data on the cell loss in the NM-containing neuronal populations by normal aging. Thus, the participation ofNM in the pathogenesis of Parkinson`s disease remains enigmatic. Biomedical Reviews 2002; 13: 39-47.

Key concepts: Neuromelanin, Catecholaminergic, Substantia nigra, Locus coeruleus, Catecholaminergic cell groups, Dopaminergic, Locus Ceruleus, Neuroscience

Related papers

Back to paper searchBrowse research topicsOriginal source
Neuromelanin-containing, catecholaminergic neurons in the human brain: ontogenetic aspects, development and aging — Research Paper | ScholarLens